David Barit

BONE SCINTIGRAPHY AS A MODALITY TO MONITOR DISEASE ACTIVITY OF CALCIPHYLAXIS IN A PATIENT WITH END-STAGE KIDNEY DISEASE SECONDARY TO DIABETIC NEPHROPATHY

J Chua, A Hannah, D Barit, D Langsford

Conference Proceedings  |  2018  |  NEPHROLOGY

PRIMARY CENTRAL NERVOUS SYSTEM POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE: AN UNCOMMON DIAGNOSTIC DILEMMA

Dov Degen, John Kanellis, Peter Hughes, David Barit, Francesco Ierino

Journal article  |  2016  |  Nephrology

Nox-4 deletion reduces oxidative stress and injury by PKC-α-associated mechanisms in diabetic nephropathy.

Vicki Thallas-Bonke, Jay C Jha, Stephen P Gray, David Barit, Hermann Haller, Harald HHW Schmidt, Melinda T Coughlan, Mark E Cooper, Josephine M Forbes, Karin AM Jandeleit-Dahm

Journal article  |  2014  |  Physiological Reports

Current treatments for diabetic nephropathy (DN) only result in slowing its progression, thus highlighting a need to identify nove..

Genetic Targeting or Pharmacologic Inhibition of NADPH Oxidase Nox4 Provides Renoprotection in Long-Term Diabetic Nephropathy

Jay C Jha, Stephen P Gray, David Barit, Jun Okabe, Assam El-Osta, Tamehachi Namikoshi, Vicki Thallas-Bonke, Kirstin Wingler, Cedric Szyndralewiez, Freddy Heitz, Rhian M Touyz, Mark E Cooper, Harald HHW Schmidt, Karin A Jandeleit-Dahm

Journal article  |  2014  |  Journal of the American Society of Nephrology

Role of Nox2 in diabetic kidney disease

Young-Hyun You, Shinichi Okada, San Ly, Karin Jandeleit-Dahm, David Barit, Tamehachi Namikoshi, Kumar Sharma

Journal article  |  2013  |  American Journal of Physiology-Renal Physiology

Post-Stroke Inhibition of Induced NADPH Oxidase Type 4 Prevents Oxidative Stress and Neurodegeneration

Christoph Kleinschnitz, Henrike Grund, Kirstin Wingler, Melanie E Armitage, Emma Jones, Manish Mittal, David Barit, Tobias Schwarz, Christian Geis, Peter Kraft, Konstanze Barthel, Michael K Schuhmann, Alexander M Herrmann, Sven G Meuth, Guido Stoll, Sabine Meurer, Anja Schrewe, Lore Becker, Valerie Gailus-Durner, Helmut Fuchs, et al.

Journal article  |  2010  |  PLoS Biology

Blood pressure lowering and outcomes in type 2 diabetes: Implications of the blood pressure-lowering arm of the advance trial

RJ MacIsaac, D Barit, G Jerums

Journal article  |  2009  |  Current Hypertension Reviews

Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes

Aino Soro-Paavonen, Anna MD Watson, Jiaze Li, Karri Paavonen, Audrey Koitka, Anna C Calkin, David Barit, Melinda T Coughlan, Brian G Drew, Graeme I Lancaster, Merlin Thomas, Josephine M Forbes, Peter P Nawroth, Angelika Bierhaus, Mark E Cooper, Karin A Jandeleit-Dahm

Journal article  |  2008  |  Diabetes

Diabetic patients and kidney protection: an attainable target

David Barit, Mark E Cooper

Journal article  |  2008  |  Journal of Hypertension

Use of magnetic resonance imaging to assess renal structure and function in reflux nephropathy

Lawrence P McMahon, John Katsoulis, John M Troupis, David Barit, Philippe Delecheneau

Journal article  |  2007  |  Nephrology